NCT00698282View on ClinicalTrials.gov

Single and Multiple Ascending Doses of AZD1981 in Japan

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Healthy
Interventions
DRUG

AZD1981

Oral tablet, 250 mg single dose

DRUG

AZD1981

Suspension, 15, 75, 1000 and 2000 mg

DRUG

Placebo

Trial Locations (1)

Unknown

Research Site, Berkshire

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY